Effect of Evidence-based Evaluation on Clinical Pathway Management: Reflection and Exploration_Chinese Journal of Evidence-Based Medicine

Authors：

 LIYou-ping ¹ , SUGuan-yue ^1,2 , YUJia-jie ¹

1. Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, China;
2. Institute of Biomedical Engineering, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, China;

Corresponding author：

Keywords：

Evidence-based evaluation; Clinical pathway management; Clinical guidelines

DOI：

10.7507/1672-2531.20160190

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Strengthening the management and evaluation of clinical pathways is one of the most important strategies of "Healthy China 2030" Strategic Plan. Evidence-based assessment and clinical guidelines can provide the best relevant evidence to develop clinical pathways. We planned to analyze the current situation of clinical pathways in China and explore how to apply evidence-based assessment on clinical pathway management. We searched PubMed, EMbase, ISI, CNKI, WanFang Data, VIP and the The Cochrane Library using "critical pathways" and "clinical guidelines" as key words or subject terms. And we conducted a comparison of their published volume, definitions, differences and connections. The management system of clinical pathway in China is fundamentally flawed, it is still a challenge to implement the clinical pathways effectively without scientific methodologies and standardized evidence-based evaluation system. In order to improve the management quality of clinical pathway in China, we should develop clinical pathways based on national situation and innovate the evaluation system to standardize the clinical pathway management according to WHO recommendations of clinical guideline and appraisal.

Citation： LIYou-ping, SUGuan-yue, YUJia-jie. Effect of Evidence-based Evaluation on Clinical Pathway Management: Reflection and Exploration. Chinese Journal of Evidence-Based Medicine, 2016, 16(11): 1250-1255. doi: 10.7507/1672-2531.20160190 Copy

1.	陈衡.临床路径概述.医学信息, 2011, 24(9):4940-4941.
2.	李明子.临床路径的基本概念及其应用.中华护理杂志, 2010, 45(1):59-61.
3.	高慧, 杨连招.临床护理路径的研究现状与发展.全科护理, 2015, 13(36):3653-3656.
4.	徐宇红, 孙勇, 杨俊玲, 等.临床路径在医学领域的发展现状及展望.护理研究, 2006, 20(3):659-661.
5.	王思成.基于循证的中医临床路径研制方法研究.北京中医药大学, 2010, 19(5):65-67.
6.	徐宇红, 孙勇, 杨俊玲, 等.临床路径在医学领域的发展现状及展望.护理研究, 2006, 20(172):659-661.
7.	中华人民共和国国家卫生和计划生育委员会.全国临床路径管理试点工作总结评估情况. 2012-04-13. Available at:http://www.nhfpc.gov.cn/tigs/s9661/201206/c3d1e5948eb947ad944e0e96b1d1734f.shtml.
8.	任馨云, 高菊玲.浅析公立医院实行临床路径的优点.求医问药, 2012, 10(3):177-178.
9.	WHO Handbook for Guideline Development. Available at:http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf?ua=1&ua=1.
10.	Clinical Practice Guidelines We Can Trust:Health and Medicine Division. Available at:http://www.nationalacademies.org/hmd/Reports/2011/Clinical-Practice-Guidelines-We-Can-Trust.aspx.
11.	NICE guidance. About. What we do. Available at:https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance.
12.	Kinsman L, Rotter T, James E, et al. Correspondence what is a clinical pathway? Development of a definition to inform the debate. BMC Medicine, 2010, 5(8):31.
13.	中华人民共和国国家卫生和计划生育委员会.医疗机构临床路径的制定与实施. 2012-09-14. Available at:http://www.moh.gov.cn/zwgkzt/s9494/201209/55887.shtml.
14.	国务院.国务院办公厅关于印发深化医药卫生体制改革2016年重点工作任务的通知(国办发[2016]26号). 2016-04-26. Available at:http://www.gov.cn/zhengce/content/2016-04/26/content_5068131.htm.
15.	吴燕子, 曹祝萍, 马集云, 等.对临床路径应用中若干问题的探讨.中国医院管理, 2008, 28(5):23-24.
16.	于秋红, 白水平, 栾玉杰, 等.我国临床路径相关研究的文献回顾.护理学杂志, 2010, 25(12):85-87.
17.	张伟旋, 夏萍, 吴大嵘, 等.我国临床路径评价指标的循证分析.中国循证医学杂志, 2012, 12(6):651-655.
18.	丁泓帆, 杨楠, 邓围, 等. WHO指南制定的基本原则和方法.中国循证医学杂志, 2016, 16(4):471-477.
19.	李幼平, 李静, 孙鑫, 等.循证医学在中国的起源与发展:献给中国循证医学20周年.中国循证医学杂志, 2016, 16(1):2-6.

1. 陈衡.临床路径概述.医学信息, 2011, 24(9):4940-4941.
2. 李明子.临床路径的基本概念及其应用.中华护理杂志, 2010, 45(1):59-61.
3. 高慧, 杨连招.临床护理路径的研究现状与发展.全科护理, 2015, 13(36):3653-3656.
4. 徐宇红, 孙勇, 杨俊玲, 等.临床路径在医学领域的发展现状及展望.护理研究, 2006, 20(3):659-661.
5. 王思成.基于循证的中医临床路径研制方法研究.北京中医药大学, 2010, 19(5):65-67.
6. 徐宇红, 孙勇, 杨俊玲, 等.临床路径在医学领域的发展现状及展望.护理研究, 2006, 20(172):659-661.
7. 中华人民共和国国家卫生和计划生育委员会.全国临床路径管理试点工作总结评估情况. 2012-04-13. Available at:http://www.nhfpc.gov.cn/tigs/s9661/201206/c3d1e5948eb947ad944e0e96b1d1734f.shtml.
8. 任馨云, 高菊玲.浅析公立医院实行临床路径的优点.求医问药, 2012, 10(3):177-178.
9. WHO Handbook for Guideline Development. Available at:http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf?ua=1&ua=1.
10. Clinical Practice Guidelines We Can Trust:Health and Medicine Division. Available at:http://www.nationalacademies.org/hmd/Reports/2011/Clinical-Practice-Guidelines-We-Can-Trust.aspx.
11. NICE guidance. About. What we do. Available at:https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance.
12. Kinsman L, Rotter T, James E, et al. Correspondence what is a clinical pathway? Development of a definition to inform the debate. BMC Medicine, 2010, 5(8):31.
13. 中华人民共和国国家卫生和计划生育委员会.医疗机构临床路径的制定与实施. 2012-09-14. Available at:http://www.moh.gov.cn/zwgkzt/s9494/201209/55887.shtml.
14. 国务院.国务院办公厅关于印发深化医药卫生体制改革2016年重点工作任务的通知(国办发[2016]26号). 2016-04-26. Available at:http://www.gov.cn/zhengce/content/2016-04/26/content_5068131.htm.
15. 吴燕子, 曹祝萍, 马集云, 等.对临床路径应用中若干问题的探讨.中国医院管理, 2008, 28(5):23-24.
16. 于秋红, 白水平, 栾玉杰, 等.我国临床路径相关研究的文献回顾.护理学杂志, 2010, 25(12):85-87.
17. 张伟旋, 夏萍, 吴大嵘, 等.我国临床路径评价指标的循证分析.中国循证医学杂志, 2012, 12(6):651-655.
18. 丁泓帆, 杨楠, 邓围, 等. WHO指南制定的基本原则和方法.中国循证医学杂志, 2016, 16(4):471-477.
19. 李幼平, 李静, 孙鑫, 等.循证医学在中国的起源与发展:献给中国循证医学20周年.中国循证医学杂志, 2016, 16(1):2-6.

Chinese Journal of Evidence-Based Medicine

Effect of Evidence-based Evaluation on Clinical Pathway Management: Reflection and Exploration

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content